Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
27.50
-0.15 (-0.54%)
Feb 4, 2026, 3:00 PM CST

Nanjing Well Pharmaceutical Group Company Description

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China.

It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material technologies, as well as provides technical services; and manufactures and sells electronic materials.

The company also exports its products to Europe, the United States, Southeast Asia, and internationally.

The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020.

Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.

Nanjing Well Pharmaceutical Group Co.,Ltd.
CountryChina
Founded2000
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees711
CEORenrong Wu

Contact Details

Address:
Building 5,No. 64 Suning Avenue
Nanjing, 210042
China
Phone86 25 8317 2922
Websitewell-js.com

Stock Details

Ticker Symbol603351
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100003JD4
SIC Code2990

Key Executives

NamePosition
Renrong WuChairman and Chief Executive Officer
Qunsong TangVice President, Secretary of the Board of Directors and Chief Financial Officer
Zhengsong GaoDirector, Vice President and Chief Engineer
Xinguo ChenDirector and Vice President
Jianguo ZouVice President
Yi YangAccounting Supervisor